Sawai Group Holdings Co., Ltd. (TYO:4887)
Japan
· Delayed Price · Currency is JPY 1,786.50
+20.00 (1.13%)
May 30, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Circulatory System Drugs | 42.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Circulatory System Drugs Growth | -14.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central Nervous System Drugs | 24.57B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central Nervous System Drugs Growth | -41.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive System Drugs | 19.09B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digestive System Drugs Growth | 3.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Metabolic Drugs | 18.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Metabolic Drugs Growth | 14.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood and Body Fluid Drugs | 16.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Blood and Body Fluid Drugs Growth | -2.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibiotics | 9.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Antibiotics Growth | 15.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vitamins | 7.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vitamins Growth | -0.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Allergy Drugs | 6.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Allergy Drugs Growth | 6.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology Drugs | 6.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 27.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -10.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Urinogenital and Anal Drugs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Urinogenital and Anal Drugs Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemotherapy Drugs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Japan | 176.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 8.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|